Association between immune-related adverse events and clinical outcomes in advanced genitourinary cancers treated with immunotherapy: A systematic review and meta-analysis

被引：0
|
作者：
Chen, J. [1 ]
Zhang, Y. [1 ]
Ni, Y. [1 ]
Sun, G. S. [1 ]
Zeng, H. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Peoples R China
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0386
引用
收藏
页码：S598 / S598
页数：1
相关论文
共 50 条
  • [21] Outcomes following immunotherapy re-challenge after immune-related adverse event: systematic review and meta-analysis
    Park, Robin
    Lopes, Laercio
    Saeed, Anwaar
    IMMUNOTHERAPY, 2020, 12 (16) : 1183 - 1193
  • [22] Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
    Hong-Rui Lu
    Peng-Fei Zhu
    Ya-Ya Deng
    Zhe-Ling Chen
    Liu Yang
    Clinical and Translational Oncology, 2024, 26 : 1106 - 1116
  • [23] Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
    Lu, Hong-Rui
    Zhu, Peng-Fei
    Deng, Ya-Ya
    Chen, Zhe-Ling
    Yang, Liu
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (05): : 1106 - 1116
  • [24] Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis
    Zhao, Zhe
    Wang, Xinfeng
    Qu, Jinghan
    Zuo, Wei
    Tang, Yan
    Zhu, Huijuan
    Chen, Xiaoguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Overweight and obesity as biomarkers for survival outcomes and immune related adverse events undergoing immunotherapy - a systematic review and meta-analysis
    Trinkner, P.
    Guenther, S.
    von Bergwelt, M.
    dos Santos, Cordas D.
    Theurich, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 227 - 227
  • [26] OVERWEIGHT AND OBESITY AS BIOMARKERS FOR SURVIVAL OUTCOMES AND IMMUNE RELATED ADVERSE EVENTS UNDERGOING IMMUNOTHERAPY - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Trinkner, P.
    Guenther, S.
    von Bergwelt, M.
    dos Santos, D. Cordas
    Theurich, S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A5 - A6
  • [27] Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis
    Lin, Li
    Liu, Yu
    Chen, Chen
    Wei, Anhua
    Li, Wei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis
    Curkovic, Nina B.
    Bai, Kun
    Ye, Fei
    Johnson, Douglas B.
    CANCERS, 2024, 16 (02)
  • [29] Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors
    Seethapathy, Harish
    Street, Sarah
    Strohbehn, Ian
    Lee, Meghan
    Zhao, Sophia H.
    Rusibamayila, Nifasha
    Chute, Donald F.
    Gao, Xin
    Michaelson, Marc D.
    Rahma, Osama E.
    Choueiri, Toni K.
    McGregor, Brad
    Sonpavde, Guru
    Salabao, Cristina
    Kaymakcalan, Marina D.
    Wei, Xiao
    Gupta, Shruti
    Motwani, Shveta
    Leaf, David E.
    Reynolds, Kerry L.
    Sise, Meghan E.
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 50 - 58
  • [30] USE OF IMMUNE CHECKPOINT INHIBITORS AND RISK OF IMMUNE-RELATED ADVERSE EVENTS AMONG PATIENTS WITH ADVANCED MELANOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Chang, C. Y.
    Park, H.
    Lo-Ciganic, W.
    VALUE IN HEALTH, 2019, 22 : S89 - S89
12345